Avoidable Mortality Across US States and High-Income Countries.

IF 23.3 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL JAMA Internal Medicine Pub Date : 2025-05-01 DOI:10.1001/jamainternmed.2025.0155
Irene Papanicolas, Maecey Niksch, Jose F Figueroa
{"title":"Avoidable Mortality Across US States and High-Income Countries.","authors":"Irene Papanicolas, Maecey Niksch, Jose F Figueroa","doi":"10.1001/jamainternmed.2025.0155","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Although there are increasing differences in health policy and population health across US states over the past decade, little is known about how US states compare with other countries on avoidable mortality.</p><p><strong>Objective: </strong>To compare trends in avoidable mortality across US states and countries in the European Union (EU) and the Organisation for Economic Co-operation and Development (OECD).</p><p><strong>Design, setting, and participants: </strong>Retrospective, population-based, repeated cross-sectional study comparing changes in avoidable mortality among decedents aged 0 to 74 years in 50 US states (and Washington, DC) and 40 high-income countries between 2009 and 2021. Data analysis was conducted from May to July 2024.</p><p><strong>Main outcomes and measures: </strong>Avoidable mortality comprising both preventable deaths related to prevention and public health and treatable deaths related to timely and effective health care treatment.</p><p><strong>Results: </strong>Between 2009 and 2019, total avoidable mortality increased in all US states (median [IQR], 29.0 [20.1 to 44.2] deaths per 100 000 people), while it decreased in most comparator countries (-14.4 [-28.4 to -8.0]). During this period, variation in avoidable mortality widened across US states (2009: median [IQR], 251.1 [228.4 to 280.4]; 2019: 282.8 [249.1 to 329.5]), but narrowed in comparator countries (2009: 201.5 [166.2 to 320.8]; 2019: 187.1 [152.0 to 298.2]). During the COVID-19 pandemic (2019-2021), avoidable mortality increased for all US states (median [IQR], 101.5 [64.7 to 143.1]) and comparator countries (25.8 [9.1 to 117.7]). The states and countries that experienced the greatest increase in avoidable deaths during the COVID-19 period were those with the highest baseline avoidable mortality (Pearson ρ = 0.86; P < .001). Health spending and avoidable mortality have a consistent, negative, and significant association among comparator countries (2019: Pearson ρ = -0.7; P < .001) but no statistically significant association within US states (2019: Pearson ρ = -0.12; P = .41).</p><p><strong>Conclusions and relevance: </strong>This cross-sectional study found that the stark contrast in avoidable mortality trends between all US states compared with EU and OECD countries suggests that broad, systemic factors play a role in worsening US population health. While other countries appear to make gains in health with increases in health care spending, such an association does not exist across US states, raising questions regarding US health spending efficiency.</p>","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"583-590"},"PeriodicalIF":23.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934005/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamainternmed.2025.0155","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Although there are increasing differences in health policy and population health across US states over the past decade, little is known about how US states compare with other countries on avoidable mortality.

Objective: To compare trends in avoidable mortality across US states and countries in the European Union (EU) and the Organisation for Economic Co-operation and Development (OECD).

Design, setting, and participants: Retrospective, population-based, repeated cross-sectional study comparing changes in avoidable mortality among decedents aged 0 to 74 years in 50 US states (and Washington, DC) and 40 high-income countries between 2009 and 2021. Data analysis was conducted from May to July 2024.

Main outcomes and measures: Avoidable mortality comprising both preventable deaths related to prevention and public health and treatable deaths related to timely and effective health care treatment.

Results: Between 2009 and 2019, total avoidable mortality increased in all US states (median [IQR], 29.0 [20.1 to 44.2] deaths per 100 000 people), while it decreased in most comparator countries (-14.4 [-28.4 to -8.0]). During this period, variation in avoidable mortality widened across US states (2009: median [IQR], 251.1 [228.4 to 280.4]; 2019: 282.8 [249.1 to 329.5]), but narrowed in comparator countries (2009: 201.5 [166.2 to 320.8]; 2019: 187.1 [152.0 to 298.2]). During the COVID-19 pandemic (2019-2021), avoidable mortality increased for all US states (median [IQR], 101.5 [64.7 to 143.1]) and comparator countries (25.8 [9.1 to 117.7]). The states and countries that experienced the greatest increase in avoidable deaths during the COVID-19 period were those with the highest baseline avoidable mortality (Pearson ρ = 0.86; P < .001). Health spending and avoidable mortality have a consistent, negative, and significant association among comparator countries (2019: Pearson ρ = -0.7; P < .001) but no statistically significant association within US states (2019: Pearson ρ = -0.12; P = .41).

Conclusions and relevance: This cross-sectional study found that the stark contrast in avoidable mortality trends between all US states compared with EU and OECD countries suggests that broad, systemic factors play a role in worsening US population health. While other countries appear to make gains in health with increases in health care spending, such an association does not exist across US states, raising questions regarding US health spending efficiency.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美国各州和高收入国家可避免的死亡率。
重要性:尽管在过去的十年里,美国各州在卫生政策和人口健康方面的差异越来越大,但人们对美国各州与其他国家在可避免死亡率方面的比较知之甚少。目的:比较美国各州与欧盟(EU)和经济合作与发展组织(OECD)国家可避免死亡率的趋势。设计、环境和参与者:回顾性、基于人群的重复横断面研究,比较2009年至2021年间美国50个州(和华盛顿特区)和40个高收入国家0至74岁死者可避免死亡率的变化。数据分析时间为2024年5月至7月。主要成果和措施:可避免的死亡率,包括与预防和公共卫生有关的可预防的死亡和与及时有效的卫生保健治疗有关的可治疗的死亡。结果:在2009年至2019年期间,美国所有州的可避免死亡率均有所上升(中位数[IQR],每10万人中有29.0[20.1至44.2]例死亡),而大多数比较国的可避免死亡率均有所下降(-14.4[-28.4至-8.0])。在此期间,美国各州可避免死亡率的差异扩大(2009年:中位数[IQR], 251.1[228.4至280.4];2019年:282.8[249.1至329.5]),但在比较国家有所缩小(2009年:2015[166.2至320.8];2019: 187.1[152.0至298.2])。在2019-2021年COVID-19大流行期间,美国所有州(中位数[IQR], 101.5[64.7至143.1])和比较国(25.8[9.1至117.7])的可避免死亡率均有所上升。在COVID-19期间可避免死亡人数增加最多的州和国家是基线可避免死亡率最高的州和国家(Pearson ρ = 0.86;结论和相关性:这项横断面研究发现,与欧盟和经合组织国家相比,美国所有州可避免死亡率趋势的鲜明对比表明,广泛的系统性因素在美国人口健康状况恶化中发挥了作用。虽然其他国家似乎通过增加医疗保健支出在健康方面取得了进展,但这种联系在美国各州并不存在,这引发了对美国医疗保健支出效率的质疑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JAMA Internal Medicine
JAMA Internal Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
43.50
自引率
1.30%
发文量
371
期刊介绍: JAMA Internal Medicine is an international, peer-reviewed journal committed to advancing the field of internal medicine worldwide. With a focus on four core priorities—clinical relevance, clinical practice change, credibility, and effective communication—the journal aims to provide indispensable and trustworthy peer-reviewed evidence. Catering to academics, clinicians, educators, researchers, and trainees across the entire spectrum of internal medicine, including general internal medicine and subspecialties, JAMA Internal Medicine publishes innovative and clinically relevant research. The journal strives to deliver stimulating articles that educate and inform readers with the latest research findings, driving positive change in healthcare systems and patient care delivery. As a member of the JAMA Network, a consortium of peer-reviewed medical publications, JAMA Internal Medicine plays a pivotal role in shaping the discourse and advancing patient care in internal medicine.
期刊最新文献
Steadying the Medical Education Pendulum-The Need for Experimental Studies. Inflammation's Impact on Ferritin in Iron Deficiency-Reply. The Continuing Burden of COVID-19 on Older Adults. Inflammation's Impact on Ferritin in Iron Deficiency. A Shark-Fin Pattern on the Electrocardiogram.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1